Outbreak of measles and rubella in refugee transit camps

Epidemiology and Infection

Volumn 137, Issue 11, 2009, Pages 1593-1601

  Kouadio, I K ^a   Koffi, A K ^b   Attoh Toure, H ^c   Kamigaki, T ^a   Oshitani, H ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c National Institute of Public Hygiene   (Côte d’Ivoire)

Author keywords

Measles; Outbreak; Refugee; Rubella; Surveillance

Indexed keywords

IMMUNOGLOBULIN M; MEASLES ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; RUBELLA ANTIBODY;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CAMPING; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MEASLES; MUMPS; RASH; REFUGEE; RUBELLA; SEROLOGY; COTE D'IVOIRE; HEALTH SURVEY; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COTE D'IVOIRE; DISEASE OUTBREAKS; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MASS IMMUNIZATION; MEASLES; MEASLES VACCINE; MEASLES-MUMPS-RUBELLA VACCINE; POPULATION SURVEILLANCE; REFUGEES; RUBELLA; SEROLOGIC TESTS;

EID: 70349574055     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809002520     Document Type: Article

References (38)

1. Whittle HC, et al. Effect of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 1988; 1: 963-966.
2. World Health Organization. The world health report 1999: making a difference. Geneva, 1999.
3. Mohan A, et al. Measles transmission following the tsunami in population with a high one dose vaccination coverage, Tamil Nadu, India 2004-2005. BMC Infectious Diseases 2006; 6: 143.
4. Bosan AH, et al. Measles mortality among Afghan refugees' children. Pakistan Journal of Medical Research 2002; 41: 43.
5. World Health Organization-United Nations Children's Fund. Joint statement on strategies to reduce measles mortality worldwide. WHO/V and B/0.1/40, 2001. (http://www.who.int/vaccines-documents/DocsPDF01/ www667.pdf). Accessed 20 February 2008.
6. Porter JDH, et al. Measles outbreaks in Mozambican refugee camps in Malawi: the continued need for an effective vaccine. International Journal of Epidemiology 1990; 19: 1072-1077.
7. Taylor WR. Measles in Vietnamese refugee children in Hong Kong. Epidemiology and Infection 1999; 122: 441-446.
8. Tool MJ, Waldman RJ. An analysis of mortality trends among refugees population in Somalia, Sudan and Thailand. Bulletin of the World Health Organization 1988; 66: 237-247.
9. Morley D, Martin W, Allen I. Measles in east and central Africa. East African Medical Journal 1967; 44: 497-508.
10. Kamugisha C, Cairn KL, Akim C. An outbreak of measles in Tanzanian refugee camps. Journal of Infectious Diseases 2003; 187 (Suppl. 1) : 58-62.
11. World Health Organization/United Nations Children's Fund. Measles: mortality reduction and regional elimination strategic plan 2001-2005. WHO/V and B/01.13 March 2003 (http://www.who.int/vaccines-documents/ DocsPDF01/www573. pdf). Accessed 26 March 2008.
12. World Health Organization-United Nations Children's Fund. Joint statement on reducing measles mortality in complex emergencies. WHO/v and B/0.4.03 ; 2004. (http://www.unicef.at/fileadmin/medien/pdf/ Measles-Emergencies.pdf). Accessed 23 February 2008.
13. Redd SC, Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3rd edn. Philadelphia, PA: Saunders, 1999, pp. 222-267.
14. Moore PS, et al. Mortality rate in displaced and resident populations of central Somalia during 1992 famine. Lancet 1993; 341: 935-938.
15. Shears P, et al. Epidemiological assessment of health and nutrition of Ethiopian refugees in emergency camps in Sudan 1985. British Medical Journal 1987; 295: 314-318.
16. Ramamurty N, et al. Investigation of measles and rubella outbreaks in Tamil Nadu, India - 2003. Journal of Medical Virology 2006; 78: 508-513.
17. Banatvala JE. Rubella - could do better. Lancet 1998; 351: 849-850.
18. World Health Organization. Outbreak news: rubella vaccine. Weekly Epidemiological Record 2000; 75: 161-172.
19. Gayer M, et al. Conflict and emerging infectious diseases. Emerging Infectious Diseases 2007; 13: 11.
20. Wyndham J. The challenges of internal displacement in west Africa. Brookings Institution-University of the Bern project on Internal displacement (http://www. fmreview.org/FMRpdfs/FMR26/FMR2639.pdf). Accessed 21 January 2009.
21. Riddell M, Rota JS, Rota PA. Review of the temporal and geographical distribution of measles virus genotypes in the pre-vaccine and post-vaccine eras. Virology Journal 2005; 2: 87.
22. Kouomou DW, et al. Measles virus strains circulating in central and West Africa : geographical distribution of two B3 genotypes. Journal of Medical Virology 2002; 68: 433-440.
23. El Mubarak HS, et al. Genetic characterization of wildtype measles viruses circulating in suburban Khartoum, 1997-2000. Journal of General Virology 2002; 83: 1437-1443.
24. Mosquera MM, Ory F, Echevarria JE. Measles virus genotype circulation in Spain after implementation of the national measles elimination plan 2001-2003. Journal of Medical Virology 2005; 75: 137-146.
25. Lawn JE, et al. Unseen blindness, unheard deafness, and unrecorded death and disability : congenital rubella in Kumasi, Ghana. American Journal of Public Health 2000; 90: 1555-1561.
26. Rota J, et al. Identical genotype B3 sequences from measles patients in 4 countries, 2005. Emerging Infectious Diseases Journal 2006; 12: 1779-1781.
27. Barnett ED, Christiansen D, Figueira M. Seroprevalence of measles, rubella, and varicella in refugees. Clinical Infectious Diseases 2002; 35: 403-408.
28. Oxfam GB. The SPHERE Project : Humanitarian charter and minimum standards in disaster response. Oxford, UK, 1998.
29. World Health Organization (WHO) database. Reported estimated of immunization coverage time series (http:// www.who.int/immunization-monitoring/ en/globalsum mary/timeseries/tscoveragebcg.htm). Accessed 8 May 2008.
30. Ministry of Health of Kenya and the World Health Organization. Measles immunity in the first year after birth and the optimum age for vaccination in Kenyan children. Bulletin of the World Health Organization 1977; 55: 21-30.
31. Loenig WEK, Coovadia HM. Age-specific occurrence rate of measles in urban, peri-urban and rural environments: implication for time of vaccination. Lancet 1983; 127: 788-794.
32. Taylor WR, et al. The importance of measles in children under nine months in urban Africa. American Journal of Epidemiology 1988; 127: 788-794.
33. Aaby P, et al. Overcrowding and intensive exposure as determinants of measles mortality. American Journal of Epidemiology 1984; 120: 49-63.
34. Coronado F, et al. Retrospective measles outbreak investigation : Sudan, 2004. Journal of Tropical Pediatrics 2006; 52 (Suppl. 5) : 329-334.
35. Gomwalk NE, Ahmad AA. Prevalence of rubella antibodies on the African continent. Reviews of Infectious Diseases 1989; 11: 116-121.
36. Aksit S, et al. Rubella seroprevalence in an unvaccinated population in Izmir: recommendations for rubella vaccination in Turkey. Pediatric Infectious Diseases Journal 1999; 18: 577-580.
37. Medecin sans Frontiere (MSF). Refugee Health: An Approach to Emergency Situations. London: Macmillan Education Ltd, 1997.
38. Toole MJ, et al. Measles prevention and control in emergency settings. Bulletin of the World Health Organization 1989; 67 (Suppl. 4) : 381-388.